Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

FHMLSP, L.L.C. — Avalanche Biotechnologies, Inc. insider: 1 transactions · InsiderLens

Home / Insiders / FHMLSP, L.L.C.

FHMLSP, L.L.C.

10% owner at Avalanche Biotechnologies, Inc. · on record since Dec 9, 2025
10% owner at Viridian Therapeutics, Inc.\DE · on record since Sep 28, 2021

Insider trading activity of FHMLSP, L.L.C.

Transactions on record: 1; since Dec 9, 2025

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Dec 9, 2025

Figures computed from official regulatory filings — methodology.

Companies where FHMLSP, L.L.C. has traded

Avalanche Biotechnologies, Inc.1 tx · $15.3M · Dec 9, 2025

Track record of FHMLSP, L.L.C.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of FHMLSP, L.L.C.

Co-insiders of FHMLSP, L.L.C.

FHMLSP, L.P.Avalanche Biotechnologies, Inc. +1
Frazier Life Sciences Public Fund, L.P.Avalanche Biotechnologies, Inc. +1
Ajer Jeffrey RobertViridian Therapeutics, Inc.\DE
Bain LindaAvalanche Biotechnologies, Inc.
Barone Samuel B.Avalanche Biotechnologies, Inc.
Beckman RichardAvalanche Biotechnologies, Inc.
Beetham Thomas W.Viridian Therapeutics, Inc.\DE

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Blumenkranz Mark S.Avalanche Biotechnologies, Inc.

Braun ShirleyAvalanche Biotechnologies, Inc.

CAIN CHRISTOPHER W.Viridian Therapeutics, Inc.\DE

Carter Eric GAvalanche Biotechnologies, Inc.

Chalberg Thomas W.Avalanche Biotechnologies, Inc.

Cheng Jennifer C.Avalanche Biotechnologies, Inc.

Ciulla ThomasViridian Therapeutics, Inc.\DE

Clark JulieAvalanche Biotechnologies, Inc.

Cleveland Paul BAvalanche Biotechnologies, Inc.

Countouriotis AthenaAvalanche Biotechnologies, Inc.

DeRespino ChristopherAvalanche Biotechnologies, Inc.

D'Souza RupertAvalanche Biotechnologies, Inc.

Fairmount Funds Management LLCViridian Therapeutics, Inc.\DE

Fairmount Healthcare Fund GP LLCViridian Therapeutics, Inc.\DE

Fairmount Healthcare Fund II GP LLCViridian Therapeutics, Inc.\DE

Fairmount Healthcare Fund II L.P.Viridian Therapeutics, Inc.\DE

Fairmount Healthcare Fund L.P.Viridian Therapeutics, Inc.\DE

Finer Mitchell H.Avalanche Biotechnologies, Inc.

Fischer LaurentAvalanche Biotechnologies, Inc.

Gasmi MehdiAvalanche Biotechnologies, Inc.

Gheuens SarahViridian Therapeutics, Inc.\DE

Gonyer David AViridian Therapeutics, Inc.\DE

Graham DawnAvalanche Biotechnologies, Inc.

Harmon SethViridian Therapeutics, Inc.\DE

Harwin Peter EvanViridian Therapeutics, Inc.\DE

Hatfield Jeffrey S.Viridian Therapeutics, Inc.\DE

Hemrajani RekhaAvalanche Biotechnologies, Inc.

Hong SooAvalanche Biotechnologies, Inc.

Hove Anders DAvalanche Biotechnologies, Inc.

Hull HansAvalanche Biotechnologies, Inc.

Humer KristianViridian Therapeutics, Inc.\DE

Johnson Robert BrianViridian Therapeutics, Inc.\DE

Katz BarrettViridian Therapeutics, Inc.\DE

Kiselak TomasViridian Therapeutics, Inc.\DE

Kiss SzilardAvalanche Biotechnologies, Inc.

Koh Bong YAvalanche Biotechnologies, Inc.

LEBOW ALPHA, LLLPViridian Therapeutics, Inc.\DE

LEBOW BENNETT SViridian Therapeutics, Inc.\DE

Leonard Braden MichaelAvalanche Biotechnologies, Inc.

Leung ThomasAvalanche Biotechnologies, Inc.

Leverone Jason A.Viridian Therapeutics, Inc.\DE

Lupher, Jr. Mark L.Avalanche Biotechnologies, Inc.

Machado Clarence PatrickAvalanche Biotechnologies, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Avalanche Biotechnologies, Inc.	Dec 9, 2025	Other	-4,288,949	3.56 USD	$15.3M	SEC